Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study

J. Quinta (Toulouse, France), F. Montastruc (Toulouse, France), V. Rousseau (Toulouse, France), A. Sommet (Toulouse, France), A. Touafchia (Toulouse, France), M. Galinier (Toulouse, France), L. Guilleminault (Toulouse, France)

Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Session: Asthma pharmacology: clinical trials and mechanistic insights
Session type: Oral Presentation
Number: 3692

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Quinta (Toulouse, France), F. Montastruc (Toulouse, France), V. Rousseau (Toulouse, France), A. Sommet (Toulouse, France), A. Touafchia (Toulouse, France), M. Galinier (Toulouse, France), L. Guilleminault (Toulouse, France). Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study. 3692

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: